Toggle Main Menu Toggle Search

Open Access padlockePrints

Phase I expansion of S-222611, a reversible inhibitor of EGFR and HER2, in advanced solid tumors, including patients with brain metastases.

Lookup NU author(s): Dr Nicola Cresti, Dr Linda Hogarth

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Publication metadata

Author(s): Deva S, Baird RD, Cresti N, Garcia-Corbacho J, Hogarth L, Frenkel EP, Kawaguchi K, Arimura A, Donaldson K, Posner J, Sarker D, Jodrell DI, Plummer R, Spicer JF

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: ASCO Annual Meeting

Year of Conference: 2015

ISSN: 1527-7755

Publisher: American Society of Clinical Oncology

URL: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/2511?sid=7c67a5bc-4b82-4eed-aa51-49b1539226be

Series Title: Journal of Clinical Oncology


Actions

Find at Newcastle University icon    Link to this publication


Share